OrthoPediatrics Corp. (KIDS) Guidance & Earnings Results

On 2026-08-04 OrthoPediatrics Corp. raised guidance: "FY26 revenue raised to $265.0-269.0M from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

KIDSOrthoPediatrics Corp.Follow KIDS — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 639.7M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 27 Oct, in 3 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
4 Aug 26	Raised	FY26 revenue raised to $265.0-269.0M from $263.0-267.0M · full year
30 Apr 26	Raised	Revenue guidance raised to $263-$267M from $262-$266M · full year
26 Feb 26	Reaffirmed	FY2026 revenue $262-266M; adjusted EBITDA $25M; breakeven free cash flow · full year
12 Jan 26	Raised	FY2026 revenue $262-266M (+11-13%); Adj. EBITDA ~$25M
28 Oct 25	Raised	Revenue guidance raised to $233.5-$234.5M (14-15% growth) · full year
9 Oct 25	Lowered	Revenue guidance reduced by ~$5M from $237-242M to $233.5-234.5M · full year
5 Aug 25	Raised	FY2025 revenue raised to $237.0-242.0M from $236.0-242.0M; representing growth of 16% to 18% compared to prior year · full year

OrthoPediatrics Corp. — questions

What guidance did OrthoPediatrics Corp. give?: On 2026-08-04: "FY26 revenue raised to $265.0-269.0M from $263.0-267.0M"
When does OrthoPediatrics Corp. report earnings?: OrthoPediatrics Corp.'s next earnings report is expected on 2026-10-27.

Every figure on this page comes from OrthoPediatrics Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.